Sljedeći

Auto Play

Early Data With Olaratumab in Soft Tissue Sarcoma

3 Pogledi • 07/18/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

The panelists, Brian Van Tine, MD, PhD; Shreyaskumar Patel, MD; Robin L. Jones, MD, MRCP; Jonathan Trent, MD, PhD; and Andrew Wagner, MD; discuss phase I/II data with olaratumab and its mechanism of action.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play